Skip Standard Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
peer-reviewed.gif (582 bytes)
eid_header.gif (2942 bytes)
 EID Home | Ahead of Print | Past Issues | EID Search | Contact Us | Announcements | Suggested Citation | Submit Manuscript

Volume 9, Number 6, June 2003

Bioterrorism-related Inhalational Anthrax in an Elderly Woman, Connecticut, 2001

Kevin S. Griffith,*† Paul Mead,* Gregory L. Armstrong,* John Painter,* Katherine A. Kelley,† Alex R. Hoffmaster,* Donald Mayo,† Diane Barden,† Renee Ridzon,* Umesh Parashar,* Eyasu Habtu Teshale,* Jen Williams,* Stephanie Noviello,*‡ Joseph F. Perz,* Eric E. Mast,* David L. Swerdlow,* and James L. Hadler†
*Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Connecticut Department of Public Health, Hartford, Connecticut, USA; and ‡New York State Department of Health, Albany, New York, USA

 
 
Figure 1.
  Back to article
 

Figure 1. Bioterrorism-related inhalational anthrax cases by week of symptom onset—United States, 2001.The first two cases of inhalational anthrax occurred in Florida. Though no direct exposure source was found, environmental samples of the media company in which these two patients worked and the postal facilities serving the media company yielded Bacillus anthracis spores specifically implicating a B. anthracis–containing letter or package (4): †, the letters to Senators Thomas Daschle and Patraick Leahy were postmarked in the Trenton, New Jersey, processing and distribution center on October 9, 2001; black bars indicate cases of inhalational anthrax in persons with direct exposure to a B. anthracis–containing letter; gray bars indicate cases of inhalational anthrax persons with no known B. anthracis exposure.

 

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed May 1, 2003

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention